BioWorld

Feb. 18, 2003

Neose Secures $17M Privately To Advance Internal Programs

Neose Technologies Inc. is raising $17 million through a private placement of common stock. The Horsham, Pa.-based company said late Thursday it entered into a definitive agreement to sell about 2.9 million common shares for $6 apiece. (BioWorld Today) Read More

GSK's Decision To Limit Sales Rankles Some Representatives

By Walling Off Cyanide, Scientists Seek Pollution-Free Hydrogen Fuel For Industry, Medical Applications

Vertex, GSK Present Preliminary Results From Two Pivotal Trials

Holiday Notice

BioWorld's offices were closed Monday in observance of the Presidents Day holiday in the U.S. No issue was published that day. Read More

Dolly, A Symbol Of Biotech, Dies At 6 From Lung Disease

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for July 24, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for July 21, 2026

To viral or not to viral: In vivo CAR T debates delivery tech

BioWorld Science

The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...

To viral or not to viral: In vivo CAR T debates delivery tech

BioWorld Asia

The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...

4D Nucleome opens new wave of gene regulation research, discovery

BioWorld

After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...